Chemometec As Stock Return On Asset
| CHEMM Stock | DKK 287.60 10.00 3.36% |
ChemoMetec AS fundamentals help investors to digest information that contributes to ChemoMetec's financial success or failures. It also enables traders to predict the movement of ChemoMetec Stock. The fundamental analysis module provides a way to measure ChemoMetec's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ChemoMetec stock.
ChemoMetec |
ChemoMetec AS Company Return On Asset Analysis
ChemoMetec's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current ChemoMetec Return On Asset | 0.31 |
Most of ChemoMetec's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ChemoMetec AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, ChemoMetec AS has a Return On Asset of 0.3117. This is 110.79% lower than that of the Life Sciences Tools & Services sector and 109.56% lower than that of the Health Care industry. The return on asset for all Denmark stocks is notably lower than that of the firm.
ChemoMetec Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ChemoMetec's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ChemoMetec could also be used in its relative valuation, which is a method of valuing ChemoMetec by comparing valuation metrics of similar companies.ChemoMetec is currently under evaluation in return on asset category among related companies.
ChemoMetec Fundamentals
| Return On Equity | 0.49 | |||
| Return On Asset | 0.31 | |||
| Profit Margin | 0.39 % | |||
| Operating Margin | 0.50 % | |||
| Current Valuation | 14.38 B | |||
| Shares Outstanding | 17.4 M | |||
| Shares Owned By Insiders | 10.87 % | |||
| Shares Owned By Institutions | 51.35 % | |||
| Price To Earning | 197.96 X | |||
| Price To Book | 40.83 X | |||
| Price To Sales | 32.10 X | |||
| Revenue | 428.39 M | |||
| Gross Profit | 384.25 M | |||
| EBITDA | 224.86 M | |||
| Net Income | 159.47 M | |||
| Cash And Equivalents | 209.02 M | |||
| Cash Per Share | 12.01 X | |||
| Total Debt | 6.79 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 2.57 X | |||
| Book Value Per Share | 26.27 X | |||
| Cash Flow From Operations | 176.86 M | |||
| Earnings Per Share | 10.15 X | |||
| Target Price | 1000.0 | |||
| Number Of Employees | 162 | |||
| Beta | 1.37 | |||
| Market Capitalization | 8.48 B | |||
| Total Asset | 501.27 M | |||
| Retained Earnings | 36 M | |||
| Working Capital | 25 M | |||
| Current Asset | 33 M | |||
| Current Liabilities | 8 M | |||
| Annual Yield | 0 % | |||
| Net Asset | 501.27 M |
About ChemoMetec Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ChemoMetec AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ChemoMetec using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ChemoMetec AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ChemoMetec in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ChemoMetec's short interest history, or implied volatility extrapolated from ChemoMetec options trading.
Pair Trading with ChemoMetec
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ChemoMetec position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ChemoMetec will appreciate offsetting losses from the drop in the long position's value.Moving against ChemoMetec Stock
| 0.41 | MAERSK-A | AP Mller | PairCorr |
The ability to find closely correlated positions to ChemoMetec could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ChemoMetec when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ChemoMetec - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ChemoMetec AS to buy it.
The correlation of ChemoMetec is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ChemoMetec moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ChemoMetec AS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ChemoMetec can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ChemoMetec AS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for ChemoMetec Stock analysis
When running ChemoMetec's price analysis, check to measure ChemoMetec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ChemoMetec is operating at the current time. Most of ChemoMetec's value examination focuses on studying past and present price action to predict the probability of ChemoMetec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ChemoMetec's price. Additionally, you may evaluate how the addition of ChemoMetec to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |